Rapid conversion to high xanthine oxidase activity in viable Kupffer cells during hypoxia
Wiezorek, J S, Brown, D H, Kupperman, D E, Brass, C A
Published in The Journal of clinical investigation (01.12.1994)
Published in The Journal of clinical investigation (01.12.1994)
Get full text
Journal Article
Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
Bennett, L., Zhao, Z., Barber, B., Zhou, X., Peeters, M., Zhang, J., Xu, F., Wiezorek, J. S., Douillard, J.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Evaluation of gene mutations beyond KRAS as predictive biomarkers of response to panitumumab in a randomized, phase III monotherapy study of metastatic colorectal cancer (mCRC)
Oliner, K., Peeters, M., Siena, S., Van Cutsem, E., Huang, J., Humblet, Y., Van Laethem, J., Andre, T., Wiezorek, J. S., Patterson, S. D.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
A placebo-controlled, randomized phase II study of conatumumab (C) or AMG 479 (A) or placebo (P) plus gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (mPC)
Kindler, H. L., Richards, D. A., Stephenson, J., Garbo, L. E., Rocha Lima, C. S., Safran, H., Wiezorek, J. S., Feigal, E. G., Bray, S., Fuchs, C.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article